And perhaps most importantly, the government won’t negotiate drug prices for people with little or no private insurance. Seniors who rely on Medicare use the most health care and are an important constituency, but more than 200 million people still pay unlimited drug costs. For example, the new law makes insulin payments $35 a month, which is good news for people who want to stay alive. But again, that provision applies to 3.3 million insulin users In Medicare, not for the millions of other people who don’t have insurance. Privately covered.
Democratic candidates may try to use this marginalization to their political advantage. The bill in the Senate includes a co-payment cap for insulin for people with private insurance. But Senate Republicans voted against the provision, ruling it did not comply with budget rules.
One of the most concrete provisions of the law is to reduce drug costs for Medicare beneficiaries, especially those with high drug costs. Out-of-pocket drug costs are covered at $2,000 a year, saving thousands of dollars for some patients with expensive diseases like cancer. More than a million Although most enrollees do not have enough drug costs to qualify in any given year, Medicare beneficiaries benefit from this cap each year.
Another major health care provision in the bill would extend enhanced ACA premium support for three years through 2025. These subsidies were added as part of the 2021 plan to save America and are saving ACA enrollees an average of more than $700 per year. Premium, is slated to expire later this year. If Congress had not acted, premiums would have been available. The sky is broken At 53 percent, ads to consumers before the election. Although Democrats can’t even promise lower premiums, they can say they’ve averted huge premium increases — and the resulting political headaches.
After passing the Inflation Relief Act, Democrats will head into the midterm campaigns with a strong message to voters about relief from health care costs. However, while their platform is popular, its reach is limited. Drug price restrictions do not apply immediately or to everyone, and drug labels Less than 10 percent Health costs.
As always, the election results have consequences. Indeed, with the outcome of the drug price negotiations delayed until 2026 and the revised ACA premium assistance ending that year, these elections and those in 2024 could determine the shape of health care affordability in the future.